| Red emitting, cucurbituril-capped, pH-responsive conjugated oligomer-based nanoparticles for drug delivery and cellular imaging J Pennakalathil, E Jahja, ES Ozdemir, O Konu, D Tuncel Biomacromolecules 15 (9), 3366-3374, 2014 | 78 | 2014 |
| Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2 ES Ozdemir, H Jang, A Gursoy, O Keskin, Z Li, DB Sacks, R Nussinov Journal of Biological Chemistry 293 (10), 3685-3699, 2018 | 51 | 2018 |
| Methods for discovering and targeting druggable protein-protein interfaces and their application to repurposing ES Ozdemir, F Halakou, R Nussinov, A Gursoy, O Keskin Computational Methods for Drug Repurposing, 1-21, 2019 | 36 | 2019 |
| Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells HH Le, SS Cinaroglu, EC Manalo, A Ors, MM Gomes, BD Sahbaz, ... EBioMedicine 73, 2021 | 29 | 2021 |
| Analysis of single amino acid variations in singlet hot spots of protein–protein interfaces ES Ozdemir, A Gursoy, O Keskin Bioinformatics 34 (17), i795-i801, 2018 | 25 | 2018 |
| Oncogenic K-Ras4B dimerization enhances downstream mitogen-activated protein kinase signaling S Muratcioglu, C Aydin, E Odabasi, ES Ozdemir, EN Firat-Karalar, H Jang, ... Journal of molecular biology 432 (4), 1199-1215, 2020 | 20 | 2020 |
| Developments in integrative modeling with dynamical interfaces ES Ozdemir, R Nussinov, A Gursoy, O Keskin Current opinion in structural biology 56, 11-17, 2019 | 15 | 2019 |
| Arl2-mediated allosteric release of farnesylated KRas4B from shuttling factor PDEδ ES Ozdemir, H Jang, A Gursoy, O Keskin, R Nussinov The Journal of Physical Chemistry B 122 (30), 7503-7513, 2018 | 14 | 2018 |
| Ras multimers on the membrane: Many ways for a heart-to-heart conversation ES Ozdemir, AM Koester, X Nan Genes 13 (2), 219, 2022 | 10 | 2022 |
| CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer H Shehwana, AG Keskus, ES Ozdemir, AA Acikgöz, R Biyik-Sit, I Cagnan, ... Cellular Oncology 44 (2), 453-472, 2021 | 8 | 2021 |
| Relation between protein intrinsic normal mode weights and pre-existing conformer populations B Ozgur, ES Ozdemir, A Gursoy, O Keskin The Journal of Physical Chemistry B 121 (15), 3686-3700, 2017 | 6 | 2017 |
| How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned? ES Ozdemir, SV Ranganathan, R Nussinov Expert Opinion on Drug Discovery 17 (10), 1061-1065, 2022 | 4 | 2022 |
| In silico screening and testing of FDA-approved small molecules to block SARS-CoV-2 entry to the host cell by inhibiting Spike protein cleavage ES Ozdemir, HH Le, A Yildirim, SV Ranganathan Viruses, 2022 | 4 | 2022 |
| Pathogen-driven cancers from a structural perspective: Targeting host-pathogen protein-protein interactions ES Ozdemir, R Nussinov Frontiers in Oncology 13, 1061595, 2023 | 3 | 2023 |
| Computational Modeling of TP63–TP53 Interaction and Rational Design of Inhibitors: Implications for Therapeutics ES Ozdemir, MM Gomes, JM Fischer Molecular cancer therapeutics 21 (12), 1846-1856, 2022 | 3 | 2022 |
| Mutation of the peptide-regulated transcription factor ComR for amidated peptide specificity and heterologous function in Lactiplantibacillus plantarum WCFS1 M Brasino, E Wagnell, ES Ozdemir, S Ranganathan, J Merritt Microbiology Spectrum, e00517-24, 2024 | | 2024 |
| A computationally guided approach to improve expression of VHH binders ES OZDEMIR, J Tolley, F Goncalves, M Gomes, E Wagnell, B Branchaud, ... bioRxiv, 2024.09. 07.611840, 2024 | | 2024 |
| Understanding Rho GTPase interactions with scaffolding proteins and Ras protein shuttling mechanisms ES Özdemir Koç University, 2018 | | 2018 |
| qPCR validation of in vivo diagnostic importance and regulation by estrogen for CHRNA5 isoform expression in breast cancer ES Özdemir PQDT-Global, 2014 | | 2014 |
